T 0159/16 (High Concentration Antibody Formulation / CHUGAI) of 11.12.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T015916.20181211
- Date of decision
- 11 December 2018
- Case number
- T 0159/16
- Online on
- 22 January 2019
- Petition for review of
- -
- Application number
- 08866971.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION
- Applicant name
- Chugai Seiyaku Kabushiki Kaisha
F. Hoffmann-La Roche AG - Opponent name
- Glaxo Group Limited
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 100(c)
- Keywords
- Inventive step - main request (no)
Inventive step - auxiliary request (yes)
Amendments - intermediate generalisation - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the Opposition Division with the order to maintain the patent on the basis of the fourth auxiliary request, filed with letter dated 9 November 2018 and a description to be adapted.